We strive for original, market-differentiating, and proprietary technologies and products. The company’s strategy is to focus on product-driven technology development and early-stage product development by seeking grant funding. The advanced development and commercialization of successful technologies and product candidates will be pursued through collaboration and partnership. The company has successfully obtained competitive grant funding for vaccine development. 
The company personnel have strong expertise in vaccines, nanoparticle carriers, polysaccharides, and formulation/delivery technologies. Our experience ranges from discovery research, preclinical development, pilot cGMP, preparation to approval.
                                                                       To discover and develop..., there is no expert on unknown™
(c) 2018 